Please wait while the formulary information is being retrieved.
ROPIVACAINE HCL (ROPIVACAINE HCL/PF)
- Regional anesthesia for labor pain
- Regional anesthesia for postoperative pain
- Regional anesthesia for surgery
- Administration of local anesthesia
- Local anesthesia for procedure
- Major nerve block for surgery
- Regional anesthesia for c-section
ropivacaine (PF) 10 mg/mL (1 %) injection solution
- Dosage information is not available
ropivacaine (PF) 2 mg/mL (0.2 %) injection solution
- Dosage information is not available
ropivacaine (PF) 5 mg/mL (0.5 %) injection solution
- Dosage information is not available
ropivacaine (PF) 7.5 mg/mL (0.75 %) injection solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Methemoglobinemia
Contraindicated
- Atrial fibrillation
- Bradycardia
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from PK and g6PD deficiencies
- Myasthenia gravis
- Plasma cholinesterase deficiency
- Structural disorder of heart
Severe
Moderate
- Disease of liver
- Kidney disease with reduction in GFR
ROPIVACAINE HCL (ROPIVACAINE HCL/PF)
- Regional anesthesia for labor pain
- Regional anesthesia for postoperative pain
- Regional anesthesia for surgery
- Administration of local anesthesia
- Local anesthesia for procedure
- Major nerve block for surgery
- Regional anesthesia for c-section
- Hypotension
- Nausea
- None
More Frequent
Severe
Less Severe
- Back pain
- Bradycardia
- Fever
- Headache disorder
- Pain
- Paresthesia
- Vomiting
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Blurred vision
- Chills
- Chondrolysis of articular cartilage
- Dizziness
- Drowsy
- Dysgeusia
- Head sensation disturbance
- Hemiparesis
- Hypertension
- Nervousness
- Pruritus of skin
- Seizure disorder
- Slurred speech
- Tachycardia
- Tremor
- Twitching
- Unconsciousness
- Urinary retention
- Ventricular arrhythmias
Less Severe
- Injection site sequelae
- Oral hypoesthesia
- Symptoms of anxiety
- Tinnitus
- Visual changes
Contraindicated
None
Severe Precaution
Ropivacaine
Rare risk of methemoglobinemia in infants age < 6 months. Limited data available. No safety and efficacy per manufacturer.
- 1 Day – 18 Years
- Rare risk of methemoglobinemia in infants age < 6 months. Limited data available. No safety and efficacy per manufacturer.
Management or Monitoring Precaution
None
Ropivacaine
- Severity Level:
2
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ropivacaine
Rat studies suggest excretion occurs; insufficient human data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Rat studies suggest excretion occurs; insufficient human data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Regional anesthesia for c-section | |
| O82 | Encounter for cesarean delivery without indication |
| Regional anesthesia for postoperative pain | |
| G89.12 | Acute post-thoracotomy pain |
| G89.18 | Other acute postprocedural pain |
| 0-9 | A-Z |
|---|---|
| G89.12 | Acute post-thoracotomy pain |
| G89.18 | Other acute postprocedural pain |
| O82 | Encounter for cesarean delivery without indication |
Formulary Reference Tool